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Background: Spleen-preserving laparoscopic distal pancreatectomy is technically challenging. New surgical robotic
systems are now available and show promising outcomes but were very recently implemented in China.
Methods: Seven patients underwent laparoscopic distal pancreatectomy using the da Vinci Robotic System (RDP)
for benign or borderline malignant pancreatic tumors. Spleen preservation rate, blood loss, and operative
complications were assessed.
Results: Mean age was 44.6 ± 13.7 years. Surgery was uneventful in all patients, without conversion to laparotomy. The
surgical time (including anesthesia induction, robot docking, operation, and postoperative awaking time) was 460 ±
154 min, while the operation time was 368 ± 126 min. Blood losses were 200 ± 110 mL. The minor (Clavien I+II)
complication rate was 14.3 %, and the major (Clavien III+IV) complication rate was 14.3 %, including hemorrhage and
pancreatic leakage. The spleen preservation rate was 100 %. All complications were successfully managed and cured.
Intraoperative laparoscopic ultrasound examination successfully identified the correct surgical resection margins. Mean
postoperative hospitalization was 8.7 ± 6.6 days. No patient had to undergo a second pancreas surgery. Patients were
followed up for a median of 6.8 months (range, 6 to 22 months). All patients survived and reported few discomforts.
Conclusions: RDP is feasible and allows the preservation of the splenic vessels.
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Spleen-preserving laparoscopic distal pancreatectomy is
currently accepted for the treatment of benign and bor-
derline malignant pancreas tumors located distally.
However, preserving splenic vessels during distal pan-
createctomy is an important issue. Two procedures
(Kimura’s and Warshaw’s) allow spleen preservation dur-
ing distal pancreatectomy [1, 2]. In the Kimura proced-
ure, the splenic vessels are preserved, ensuring excellent
blood supply to the spleen [1]. In the Warshaw proced-
ure, the short gastric and left gastroepiploic arteries and
veins are preserved, but the splenic vessels are sacrificed
[2]. During traditional laparoscopic distal pancreatec-
tomy (LDP), inherent limits and shortcomings such as
limited visibility, poor ergonomics, and limited dexterity* Correspondence: djh20150603@126.com
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article, unless otherwise stated.may cause a hemorrhage from vessels’ branches, and a
conversion to open surgery may occur.
With recent advances in three-dimensional optics and
computer-enhanced motion control, robotic-assisted
surgery (RAS) achieved the potential to overcome some
of the limits observed with LDP. Indeed, it allows per-
forming complex pancreatic resections with improved
ergonomics, visualization, precision, and dexterity dur-
ing spleen-preserving LDP. Previous studies have shown
that the use of RAS was as safe and efficient as open
surgery [3, 4].
However, robotic distal pancreatectomy (RDP) was im-
plemented only recently in China, and there is a lack of
reports about this technique in Chinese patients. In this
report, we present our initial RDP experience.distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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Between June 2009 and March 2012, 28 consecutive pa-
tients diagnosed with benign or borderline masses in the
distal pancreas (by preoperative ultrasound and computer
tomography or magnetic resonance imaging) and evaluated
by the same group of surgeons at the People’s Liberation
Army General Hospital were approached for participation
in the present study. After discussion about the pros and
cons of RDP vs. LDP, patients chose the approach they
wanted, resulting in seven patients choosing RDP Table 1.
Patients who underwent LDP were included as controls for
comparing some features between RDP and LDP.
Patients underwent robotic-assisted surgery using the
da Vinci S system (Intuitive, Sunnyvale, CA, USA).
This study was approved by the Institutional Review
Board of the Chinese People’s Liberation Army General
Hospital. All possible advantages and disadvantages of
RDP were clearly explained to the patients. Written in-
formed consent was obtained from each patient.
Robotic-assisted distal pancreatectomy
RDP was performed according to the Kimura procedure
[1] by a single chief surgeon having about 30 years of ex-
perience in pancreatectomy. The patient was positioned
in a 30° reverse-Trendelenburg position with his arms
tucked at his sides and the legs in the low lithotomy
position. An intra-abdominal pressure was established
at 14 mmHg using the Veress needle technique. Five
operating trocars were placed as shown in Fig. 1a: a
12-mm camera port (C), two 8-mm da Vinci trocars
(R2, R3), one 8-mm port (R1), and a 12-mm port
(A1) for the assistant.
The lesser sac was entered by dividing the gastrocolic
ligament with preservation of the gastroepiploic artery.
The pancreas body was then exposed. In order to achieve a
better surgical exposure, R3 was used to pull up the stom-
ach, which is a much more stable approach compared with
laparoscopy, reducing the need for assistance. After a care-
ful exploration of the peritoneal cavity and viscera, intraop-
erative laparoscopic ultrasound examination was
performed using a diagnostic ultrasound machine (Aloka,
Tokyo, Japan) with a UST-5410 variable angle high-
frequency linear array probe at 4–13 MHz. The probe was
inserted into the abdominal cavity through port R1 to seek
for previously undetected lesions and to determine the ac-
curate surgical resection margins (Fig. 1b). Marks were
made with an electrotome to define the margins.
We isolated the upper and lower edges of the pancreas
on the right side of the tumor. The splenic artery and
splenic vein branches and tributaries were isolated using
an electric coagulation scalpel attached to one of the ro-
botic arms. For vascular control, ligature was more often
used, but transfixating sutures were also used if neces-
sary (Fig. 2a). These two hemostatic methods aredifficult to perform using LDP but are easy when using
RDP [5]. By dividing these structures from the pancreas
in a head-to-tail direction, the splenic artery and vein
were undamaged, and the blood supply system was com-
pletely preserved (Fig. 2b) [1]. An intraoperative ultra-
sound was performed again to identify the location of
the lesion and its relative position with vessels and other
organs and to confirm the negative margins. Splenic ar-
tery and vein were carefully identified. The dissection
then begun from the right side, with margins of 1 cm
around the tumor, using a surgical stapler (Echelon 60,
Johnson & Johnson, U.S.A, Fig. 2c). The body and tail of
the pancreas harboring the tumor were totally dissected.
After transection using the Echelon 60 surgical stapler
(Johnson & Johnson, USA), three rows of cross pins in
each incisional edge were used to tightly block the two
transverse pancreatic arteries. This was usually sufficient
to control bleeding. If bleeding occurred, 4-0 Prolene su-
ture was used (“8” suture method). Hemostasis was per-
formed on the pancreatic stump by electrocautery or
transfixation (Fig. 2d). Due to the learning curve, a
slightly improved method for splenic artery and vein
identification was used for the later cases: the pancreas
body was first transected without any vascular control,
and then the splenic vessels were identified and dis-
sected free from the pancreas towards the splenic hilum.
Using this approach, splenic artery and vein were easily
identified. After irrigation in the surgical bed, and
checking for bleeding and pancreatic leak, two drains
were systematically placed around the pancreas
stump. The specimen was then extracted from the ab-
domen using a plastic bag.Data collection and follow-up
Patients’ demographics, operative time, complications,
and length of hospital stay were recorded. The surgical
time was calculated as the time between anesthesia and
postoperative awaking time (including anesthesia induc-
tion, robot docking, operation, and postoperative awak-
ing time). The operative time was calculated as the time
between skin incision and the last port skin closure. The
exploratory laparoscopy, the robotic set up and docking,
and any associated required procedures were included in
the surgery time.
Patients were followed up during visits to the out-
patient department or by telephone. Follow-up ended at
the last visit recorded in the patient’s medical chart. The
patients were asked if they felt any discomforts and if
their work and daily life were impaired in any manner.Statistical analysis
Results are presented as means ± standard deviation.
SPSS 15.0 (SPSS Inc., Chicago, IL, USA) was used for
Table 1 Characteristics of patients who underwent RDP (n = 7)
























2 Female 44 Pancreatic serous
cystadenoma
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papillary cystadenoma
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solid-pseudopapillary
tumor
2.5 × 2 × 2 RDP,
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Mean ± SD – 44.6 ± 13.7 – – – 460 ± 154 369 ± 126 203 ± 110 11.3 ± 6.6 – – –













Fig. 1 a Port placement for RDP. C camera port (12 mm), R1 left
robotic instrument port (8 mm), R2 right robotic instrument port
(8 mm), R3 third robotic instrument port (8 mm), A1 first assistant
port (12 mm), MCL midclavicular line, AAL anterior axillary line.
b Intraoperative laparoscopic ultrasound examination of the pancreas.
Arrow 1 shows the tumor. Arrow 2 shows the splenic vessels
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Mann-Whitney test or the independent sample t test for
continuous variables, as appropriate, while the Pearson
chi-square test was used for categorical variables. Two-
sided P values ≤ 0.05 were considered significant.
Results
The seven patients who underwent RDP (five women and
two men; mean age of 44.6 ± 13.7 years, ranging 32–73)
suffered from serous cystadenomas (n = 4), islet cell tumor
(n = 1), solid pseudopapilloma (n = 1), or mucinous cysta-
denoma (n = 1). The average lesion size was 3.0 ± 0.7 cm
(2.5 to 4.0 cm).
All patients underwent the Kimura procedure. In one
patient, RDP and a right adrenal tumor resection were
performed at the same time. In another patient, RDP
and a cholecystectomy were performed at the same time.Therefore, the surgery required more time in these two pa-
tients. Intraoperative laparoscopic ultrasound examination
successfully and correctly identified surgical resection
margins.
All seven RDP procedures were successful. None re-
quired a conversion to laparotomy or LPD. Surgical mar-
gins were more than 1 cm in all cases. The mean
surgical time was 460 ± 154 min (range, 270–720 min).
The mean operative time was 368 ± 126 min (range,
220–600 min). Spleen preservation rate was 100 %.
Blood losses were 200 ± 110 mL. The mean postopera-
tive stay was 8.7 ± 6.6 days.
Complications were assessed according to the Clavien
classification of surgical complications (2004 revised ver-
sion) [6] and to the International pancreatic fistula re-
search team’s classification of postoperative pancreatic
fistula [7]. Two patients (28.6 %) suffered from at least
one complication: the minor (Clavien I+II) complication
rate was 14.3 %, and the major (Clavien III+IV) compli-
cation rate was 14.3 %. Twelve days after surgery, one
patient complained of abdominal pain. CT scan showed
a 10 × 11 × 11-cm hematoma in the gastric area, above
the pancreatic area. Hemoglobin levels were decreased
from 127 (preoperative) to 108 g/L. This intra-
abdominal hemorrhage was grade II. It was treated
using conservative treatment (hemostatics), without
blood transfusion or surgery. He was discharged with-
out any subsequent complication. One patient suf-
fered from an intraperitoneal hemorrhage and had to
undergo emergency surgery the day after RDP. About
2000 mL of blood, clots, and fluids were removed,
but no clear bleeding site could be identified. Bleed-
ing did not recur, and the patient was eventually dis-
charged without any other complications. Four
patients suffered from a pancreatic fistula (grade A)
detected by amylase values of three times the upper
value of normal from the surgical drains. The fistulas
did not require percutaneous drainage. Drainage tubes
were placed by surgery to drain the fistula. These pa-
tients did not receive somatostatin.
Total hospital costs were $10,125 per patient.
Patients were followed up for a median of 6.8 months
(range, 6 to 22 months). CT scan with contrast perform-
ing 1–2 months after surgery showed no evidence of
varicose veins near the hilum of the spleen or gastric
fundus nor thrombosis or stenosis. At the end of the
follow-up, all patients were alive and had few discomforts.
We also examined the operative characteristics of 21
consecutive patients who declined RDP and underwent
LDP. Compared with RDP, mean operative time for LDP
was shorter (210 vs. 368 min, P = 0.0002), blood losses
were comparable (250 vs. 200 mL, P = 0.45), complica-
tion rates were comparable (33.3 vs. 28.6 %, P = 0.82),
hospital stay was longer (10.6 vs. 8.7 days, P = 0.004),
Fig. 2 Robotic-assisted spleen-preserving laparoscopic distal pancreatectomy. a Ligation of the splenic vein (arrow), which passes through the
pancreas. b The pancreas is totally free from the splenic artery and vein. All branches were treated by sonic shear (<2 mm) or ligature (≥2 mm).
Splenic artery and vein were completely preserved. c Use of the surgical stapler (EC60) to perform pancreatic dissection (with ≥1-cm margin). The
tumor is indicated by an arrow. d Verification of the pancreatic section, hemorrhage, and pancreatic leak
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P = 0.0002) (Table 2).
Discussion
In the present series of patients treated using RDP at a
single institution, surgery was uneventful in all patients,
without conversion to laparotomy. The spleen preserva-
tion rate was 100 %, the minor (Clavien I+II)Table 2 Surgical outcomes, complications and hospital costs
according to the use of a robot during distal pancreatectomy
RDP (n = 7) LDP (n = 21) P value
Mean operative time (min) 368 210 0.0002








(no. of patients) (%)
0 1 (4.7)a
Mean postoperative stay (days) 8.7 10.6 0.004
Complications (no.
of patients) (%)
2 (28.6) 7 (33.3) 0.815
Grade, Clavien classification II (1), III (1) I (5), II (1), III (1)
Hospital costs ($) 10,125 6921 0.0002
RDP robot-assisted distal pancreatectomy, LDP laparoscopic
distal pancreatectomy
aA second operation was required in one patient of the LPD group (4.7 %)
who had a postoperation hemorrhagecomplication rate was 57.1 %, and the major (Clavien III
+IV) complication rate was 14.3 %. No patient had to
undergo a second pancreas surgery. All patients survived
and reported few discomforts. This study presents the
first Chinese experience using RDP. Intraoperative lap-
aroscopic ultrasound examination was performed to de-
fine the surgical resection margins, which could
contribute to better outcomes. These results are sup-
ported by a previous study by Hwang et al [8]. However,
in comparison, the present study showed a slightly shorter
operation (369 ± 126 vs. 399 ± 166 min), and blood losses
that were nearly halved (203 ± 110 vs. 360 ± 360 mL).
However, the hospital stay was longer (11 ± 7 vs. 7 ±
2 days).
Indeed, preserving the immunological functions of the
spleen can help to avoid the incidence of leukocytosis,
thrombocytosis, overwhelming post-splenectomy sepsis,
and low-grade immunodeficiency. A retrospective study
from the Memorial Sloan-Kettering Cancer Center in
125 patients who underwent distal pancreatectomy
with or without splenectomy showed that there were
postoperative complications in 49 % of patients who
underwent splenectomy vs. 39 % of patients who did
not [9]. In addition, perioperative infectious complica-
tions and severe complications were more frequent in
the splenectomy group (28 vs. 9 % and 11 vs. 2, re-
spectively). Thus, spleen preservation during distal
pancreatectomy for benign or borderline malignant
tumors is now an accepted practice.
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for preserving the spleen, but the spleen’s blood supply
cannot be guaranteed [10]. In an attempt to alleviate the
morbidity associated with splenectomy, we were inter-
ested in preserving the whole splenic blood supply dur-
ing distal pancreatectomy. The Kimura procedure
completely preserves the splenic artery and vein, as well
as perfusion of the spleen, without noticeable changes in
physiological functions. During our follow-up period, we
did not observe any evidence of varicose veins near the
hilum of the spleen or gastric fundus in RDP patients,
which might be better than outcomes achieved using the
Warshaw procedure since a previous series reported
perigastric varices in 25 % of patients during follow-up
after the Warshaw surgery [10]. However, this procedure
is difficult to perform using traditional laparoscopy, and
it is much easier to accomplish using a robotic laparos-
copy approach [5].
Since the technology allowing this approach is rela-
tively novel, RDP is believed to be an uncommon surgi-
cal procedure. Since Olah et al. [11] first reported
“robotic resection of a pancreatic neuroendocrine
tumor” in 2003, Giulianotti et al. [12] reported five pan-
creatic resections using RDP with an average surgical
time of 270 min (range, 210–360 min). Among these five
cases, only two patients (one for an insulinoma and one
for a benign cystic lesion) underwent spleen-preserving
pancreatic resection. Some other studies are also avail-
able from different countries comparing RDP vs. LDP
vs. open surgery, with or without splenic vessel preserva-
tion [13–17]. A number of case reports and small series
are also available.
Robotic surgery offers the opportunity to combine the
advantages of both minimally invasive and open surgical
approaches [4]. The patients promptly return to full ac-
tivity and have a short hospital stay. For the surgeons,
RDP has the advantage of requiring less laparoscopic ex-
perience. Furthermore, the dissection of the splenic vein
and artery and the creation of the retropancreatic tunnel
were more easily performed using the da Vinci system
compared with LDP [18]. Tumors in the body and tail of
the pancreas are commonly treated with minimally inva-
sive surgical techniques, and the advantage of decreased
tissue trauma may prove to be beneficial for a patient
with a benign disease. Thus, a minimally invasive ap-
proach should be advocated for this type of disease, par-
ticularly because of the benefits it provides in terms of
postoperative outcomes, such as improved respiratory
function and less operative stress.
According to our experience, the key feature during
RDP is freeing the upper and lower edges of the pancreas
followed by venous ligation or transfixion of the vessels
close to the hilus of the spleen. Intra-operative venous
bleeding can usually be managed with a combination ofdirect electric coagulation or sutures. Theoretically, using
a robot can greatly increase the ability to deal with small
and delicate branches of splenic vessels because of the su-
perior visualization and precision offered by the da Vinci
surgical system. Nevertheless, postoperative hemorrhage
may occur, and hemorrhage is the most common and ser-
ious complication of this surgery.
We used the EC60 stapler for managing the pancre-
atic stump because this method is simple, quick, and
known to be a safe alternative to the standard suture
closure technique [19]. We usually use the gold cart-
ridge to cutoff the pancreas because the staple length
is 3.8 mm and the closed height is then 1.8 mm,
making the pancreatic stump wrinkled, reducing the
incidence of pancreatic fistula.
However, using a robot presents a number of disad-
vantages. The surgeons who control the robot in the
surgical console do not feel any touch sensation asso-
ciated with physically touching the tissues, and they
have to rely on visual feedback only [20]. It is com-
mon to encounter a hemorrhage while grasping or
pulling the pancreas during the division of small
splenic vessels from the pancreas. Sutures or electro-
coagulation using Biclamp are two good options for
hemostasis, but these procedures are onerous in
terms of surgical time. However, compared with
laparoscopy, suture of the spleen is not so risky any-
more [5]. The setup of the robotic arms necessitates
good spatial planning and is time-consuming, espe-
cially at the beginning of the learning curve [13].
Pancreatic fistula is one of the complications that
may be encountered during RDP, but it is usually
manageable by drainage. For overweight patients, setup
and pancreatic exposure may not be easy, and one or two
supplementary ports might be necessary. Another import-
ant criticism is the higher cost of RDP compared with
LDP and is one of the main obstacles for the use of RDP
in usual clinical practice [5, 13].
In the present study, 71 % (5/7) of the patients suf-
fered from complications. A previous study reported a
complication rate of 26 % after robotic pancreatic
surgery [4], but it was reported after performing ro-
botic pancreatectomy in 134 patients (compared with
7 in the present study), which may suggest an effect
of the learning curve on the incidence of complica-
tions. In addition, this previous study [4] included all
types of pancreatectomy, while the present study fo-
cused on RDP with preservation of the splenic ves-
sels. A previous study in 246 patients who underwent
laparoscopic distal pancreatectomy showed a complication
rate of 31.3 % [21]. Previous studies also reported similar
complication rates between RDP and LDP [17, 22]. It
might be expected that with more experience, the compli-
cation rate of RDP should decrease.
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China only a few years ago. With experience and im-
provements of this technique, it is anticipated that the
hospital stay, complication rate, and costs should be im-
proved, making it more attractive than traditional ap-
proaches. Nevertheless, in the context of the Chinese
healthcare system, the hospital stay was not overtly long.
In addition, if the first two patients were excluded, the
mean hospital stay would be significantly shorter, and
the complication rates would be lower. Seemingly, in
this study and in contrast to LDP, RDP could improve
some operative characteristics (e.g., blood losses) but in-
creased the mean operative time, complication rate, and
mean hospital costs. However, since the characteristics
of the patients (e.g., age, disease type, and lesion size)
were not comparable between the RDP and LDP groups,
the treatment efficacy between the two procedures could
not be compared directly.
The present study has some limitations. Even if we
compared two groups of patients, the sample size was
too small to draw any firm conclusion. Since the patients
chose which surgical approach they wanted, based on
safety and costs, it is possible that the patients choosing
the robotic approach had a higher income than those
choosing LDP, as well as a standard of living favoring
good outcomes. However, the present report is a case
series presenting our initial experience in a newly imple-
mented technology in China. We are currently conduct-
ing a prospective trial in a larger number of patients. In
the present study, postoperative stays were particularly
long. However, this issue lays in the Chinese healthcare
system, which requires that all patients are completely
symptom-free upon discharge, which mean without any
abdominal cavity drainage tube. In addition, even mild
discomfort expressed by the patient will make the hos-
pital unwilling to discharge him.
Conclusions
Our preliminary real-life study suggests that RDP is a
feasible and lowly invasive option for the resection of
benign or borderline malignant tumors of the pancreas.
We used the Kimura procedure with RDP, and results
suggest that it is beneficial for preserving the splenic
vessels. However, postoperative complication rate and
costs were high, and hospital stay and surgical time were
long. Additional multiple-center randomized prospective
studies with a larger number of patients are required to
assess the efficacy of RDP.
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